Affordable and sustainable self-powered GLUCOSE sensing system for a global FAIR diabetes management

FAIRGLUCOSE aims to develop a low-cost, self-powered glucose sensing system that reduces waste and enhances accessibility for glucose monitoring, especially in low-income regions.

Subsidie
€ 150.000
2022

Projectdetails

Introduction

FAIRGLUCOSE proposes a low-cost, sustainable, and self-powered standalone glucose sensing system that relies on the well-known oxidation process of glucose coming from finger prick blood. This system transfers the glucose measurement to a voltage readout through an innovative and extremely simple strategy.

Device Design

In this way, a measurement that typically requires a potentiostat with a microcontroller and a battery is performed here with a minimalistic and battery-less circuit that fits within the footprint of a commercial glucose strip.

Benefits

This design allows for:

  • A reduction in device cost
  • A decrease in the generation of waste from electrical and electronic equipment (WEEE or e-waste)

By avoiding the cumulative effect of millions of tests and their corresponding batteries performed at remote sites away from adequate recycling infrastructures, the environmental impact is significantly lessened.

Result Interpretation

In order to interpret the result, the strip can be integrated into a card format that translates voltage into level bars accounting for:

  1. Low glucose indicators
  2. Normal glucose indicators
  3. High glucose indicators

This solution could substitute urine strips or be designed into a more sophisticated but still low-cost card containing an NFC chip, allowing the transfer of a numeric result into a cell phone.

Technology Implementation

Both cards could be implemented with state-of-the-art flexible electronics technologies and could be reused infinitely, as energy would always come from the sample.

Target Market

The first targeted market of FAIRGLUCOSE solutions is located in low and middle-income countries, where the cost of current glucometers severely limits the self-monitoring of blood glucose among the population.

Future Prospects

However, in the mid-term, it is likely that the sustainability and affordability of the approach will displace the current glucose players in some market niches of developed countries and generate new applications in the healthcare and agro-food arena.

Conclusion

Thus, FAIRGLUCOSE aims to investigate the commercial feasibility of this disruptive approach and create an innovation roadmap that allows deploying the technology where it can make the most impact.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-5-2022
Einddatum31-10-2023
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICASpenvoerder

Land(en)

Geen landeninformatie beschikbaar

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

self-PoweRed cONductimeter for digiTalization of rapid mOlecular diagnostics

PRONTO aims to develop a low-cost, self-powered conductimetric sensor for rapid, sensitive detection of infectious diseases, making advanced testing accessible in low- and medium-income countries.

€ 150.000
ERC Proof of...

Miniaturized flexible batteries for next generation wearable healthcare sensors

FlexiMin aims to develop a flexible, miniaturized battery to power next-gen wearable sensors for continuous biomarker monitoring, enhancing healthcare diagnostics and market readiness.

€ 150.000
ERC Proof of...

Metal-Organic-Framework Kinetic Array for Diabetes Detection

This project aims to develop a novel sensor using metal-organic frameworks to selectively detect volatile organic compounds in breath for non-invasive diabetes diagnosis.

€ 150.000
ERC Proof of...

Sensor islet organoids (SILORGS) for in vivo identification of anti-diabetic drugs

Develop a non-invasive in vivo imaging platform using sensor islet organoids in mice to assess β-cell function and survival for validating new diabetes treatments.

€ 150.000
ERC Starting...

Neuromorphic Flexible Electro/chemical Interface for in-Memory Bio-Sensing and Computing.

Develop a miniaturized, self-contained biosensing technology using neuromorphic devices for real-time monitoring and classification of neurodegenerative biomarkers in individualized healthcare.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

EIC Accelerator

The world’s first needle-free continuous glucose monitor to prevent and manage diabetes at scale

Developing a non-invasive glucose monitoring device to improve diabetes management and prevent onset for over 2 billion people through EIC blended finance support.

€ 2.500.000
EIC Transition

Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing

GLUMON aims to develop a next-gen non-invasive optoacoustic sensor for continuous blood glucose monitoring, enhancing diabetes care and exploring precision nutrition applications.

€ 2.194.210
Mkb-innovati...

Ontwikkeling betaalbare FBG sensor voor medische toepassingen

Imagin Motion ontwikkelt een betaalbare FBG sensor voor het verbeteren van medische scans en bestraling door patiëntbeweging te meten.

€ 20.000
Mkb-innovati...

GlucoMoveIQ

Het project ontwikkelt een subcutane glucosemonitor met hoge nauwkeurigheid en een batterijlevensduur van twee jaar voor betere diabeteszorg.

€ 20.000
EIC Accelerator

Minimally invasive reliAble Glucose monitoring in Intensive Care

GlucoSet aims to develop a novel continuous glucose monitor for ICU patients to improve glucose control, enhance patient outcomes, and achieve CE-mark approval within 25 months.

€ 2.500.000